Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.
Saved in:
| Title: | Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. |
|---|---|
| Authors: | Frias JP; National Research Institute, Los Angeles, California., Gonzalez-Galvez G; Jalisco Institute of Diabetes and Obesity Research, Guadalajara, Mexico., Johnsson E; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Maaske J; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Testa MA; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Simonson DC; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dronamraju N; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Garcia-Sanchez R; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Peters AL; Keck School of Medicine of the University of Southern California, Los Angeles, California. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Jul; Vol. 22 (7), pp. 1083-1093. Date of Electronic Publication: 2020 Mar 09. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32052516 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Frias+JP%22">Frias JP</searchLink>; National Research Institute, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Galvez+G%22">Gonzalez-Galvez G</searchLink>; Jalisco Institute of Diabetes and Obesity Research, Guadalajara, Mexico.<br /><searchLink fieldCode="AU" term="%22Johnsson+E%22">Johnsson E</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Maaske+J%22">Maaske J</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Testa+MA%22">Testa MA</searchLink>; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Simonson+DC%22">Simonson DC</searchLink>; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Dronamraju+N%22">Dronamraju N</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Garcia-Sanchez+R%22">Garcia-Sanchez R</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Peters+AL%22">Peters AL</searchLink>; Keck School of Medicine of the University of Southern California, Los Angeles, California. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2020 Jul; Vol. 22 (7), pp. 1083-1093. <i>Date of Electronic Publication: </i>2020 Mar 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32052516 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/dom.13997 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1083 Titles: – TitleFull: Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frias JP – PersonEntity: Name: NameFull: Gonzalez-Galvez G – PersonEntity: Name: NameFull: Johnsson E – PersonEntity: Name: NameFull: Maaske J – PersonEntity: Name: NameFull: Testa MA – PersonEntity: Name: NameFull: Simonson DC – PersonEntity: Name: NameFull: Dronamraju N – PersonEntity: Name: NameFull: Garcia-Sanchez R – PersonEntity: Name: NameFull: Peters AL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2020 Jul Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1463-1326 Numbering: – Type: volume Value: 22 – Type: issue Value: 7 Titles: – TitleFull: Diabetes, obesity & metabolism Type: main |
| ResultId | 1 |
